Atlas Trials

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Clinical trial NCT01803503 · UNKNOWN

Trial details

NCT number
NCT01803503
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Solid TumorsBreast CancerNon-small Cell Lung CancerProstate CancerGastric Cancer
Start date
2013-05-01
Primary completion
2017-04-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.